Researchers are studying GLP-1 receptor agonists for potential roles in treating alcohol use disorder, nicotine addiction, and other compulsive behaviors, though this research is still ongoing
Testing can also reveal differences in taste and flavour sensitivity, guiding food choices that support gut health, reduce discomfort, and enhance enjoyment, making nutrition more personalised and sustainable
Harpreet Singh Bajaj, MD, MPH, an endocrinologist at LMC Diabetes & Endocrinology in Toronto, Canada, will present the primary results of the first phase 3 study of retatrutide in patients with type 2 diabetes, the TRANSCEND-T2D-1 trial
Its the first week of treatment, so dont expect miracles
No specific preparation is required
Rated 5 out of 5 Kareca (verified owner) Always a great purchase, and fast shipping Rated 5 out of 5 ARTHUR D